Pralatrexaat
6- ((bromometyl)-2,4-pteridinediaminehydrobromide (52853-40-4)
6-(Bromomethyl)-2,4-pteridinediamine hydrobromide is a potent inhibitor of the enzyme nitroaldolase (EC 1.2.1.22) and has been shown to inhibit cell growth in murine leukemia cells. It is an intermediate of Pralatrexate. Product Name: 6-(Bromomethyl)-2,4-pteridinediamine hydrobromide CAS No.: 52853-40-4 Assay: 98% End Use: Pralatrexate Molecular Formula: C7H8Br2N6 Molecular Weight: 335.99 Shelf Life: 2 Years Package: 25kg/drum
Pralatrexaat (52853-40-4)
Pralatrexate, an injectable DHFR inhibitor, was launched for the treatment of patients with relapsed or refractory PTCL. The inhibition of the folate enzymes DHFR and thymidylate synthase is a well-validated method of cancer treatment. Product Name: Pralatrexate CAS No.: 52853-40-4 Assay: 989% Specification: CP, EP, In-house, as required Molecular Formula: C23H23N7O5 Molecular Weight: 477.47 Shelf Life: 2 Years Package: 25kg/drum
